We are live on ! Find out more
KIA

Kopp Investment Advisors Portfolio holdings

AUM $54.4M
1-Year Est. Return 14.33%
This Fund
S&P 500
This Quarter Est. Return
+14.5%
1 Year Est. Return
+14.33%
3 Year Est. Return
+109.21%
5 Year Est. Return
+340.72%
10 Year Est. Return
AUM
$112M
AUM Growth
+$9.39M
Cap. Flow
-$2.95M
Cap. Flow %
-2.64%
Top 10 Hldgs %
46.04%
Holding
65
New
4
Increased
20
Reduced
32
Closed
1

Sector Composition

Rank Sector Weight
1 Healthcare 48.56%
2 Technology 36.34%
3 Industrials 3.2%
4 Financials 2.81%
5 Miscellaneous 2.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QQQ icon
51
Invesco QQQ Trust
QQQ
$493B
$406K 0.36%
2,950
VCSH icon
52
Vanguard Short-Term Corporate Bond ETF
VCSH
$45.1B
$320K 0.29%
4,000
TVTY
53
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$267K 0.24%
6,693
-3,330
-33% -$111K
HZNP
54
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$263K 0.24%
+22,135
New +$275K
EW icon
55
Edwards Lifesciences
EW
$51.8B
$252K 0.23%
6,396
EGRX
56
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$241K 0.22%
3,060
+10
+0.3% +$818
TECH icon
57
Bio-Techne
TECH
$11.4B
$235K 0.21%
8,000
GE icon
58
GE Aerospace
GE
$356B
$234K 0.21%
1,807
VIG icon
59
Vanguard Dividend Appreciation ETF
VIG
$113B
$204K 0.18%
+2,200
New +$202K
ENTL
60
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
$197K 0.18%
11,874
+55
+0.5% +$765
VNDA icon
61
Vanda Pharmaceuticals
VNDA
$329M
$196K 0.18%
+12,020
New +$173K
VCEL icon
62
Vericel Corp
VCEL
$2.11B
$178K 0.16%
54,040
-1,000
-2% -$2.74K
ELGX
63
DELISTED
Endologix Inc
ELGX
$107K 0.1%
2,195
+227
+12% +$13.4K
SCON
64
DELISTED
Superconductor Technologies Inc.
SCON
$29K 0.03%
+165
New +$29.1K
SPSC icon
65
SPS Commerce
SPSC
$3.03B
-52,878
Closed -$1.55M

Similar funds

Kopp Investment Advisors's Q2 2017 Portfolio in Review

As of Q2 2017, Kopp Investment Advisors held 65 positions worth $112M, up 9.2% from $102M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Kopp Investment Advisors's Q2 2017 filing shows 4 new, 20 increased, 32 reduced and 1 closed positions. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 22,135 shares worth $263K. The largest sale was Akorn Inc, an estimated $2.38M.

By sector, the portfolio is most concentrated in Healthcare at 49% of assets, up from 46% a quarter earlier, followed by Technology and Industrials.

  • Kopp Investment Advisors's largest Q2 2017 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 22,135 shares worth $263K.
  • Kopp Investment Advisors added most to Imperva, Inc. in Q2 2017, an estimated $834K increase.
  • Kopp Investment Advisors's biggest Q2 2017 reduction was Akorn Inc, cutting an estimated $2.38M.
  • Kopp Investment Advisors fully exited SPS Commerce in Q2 2017, selling an estimated $1.55M.
  • Kopp Investment Advisors's ten largest holdings make up 46% of its $112M portfolio in Q2 2017.
  • Kopp Investment Advisors opened 4 new positions and closed 1 in Q2 2017.
  • Kopp Investment Advisors's portfolio value rose 9.2% quarter-over-quarter to $112M.

Based on Kopp Investment Advisors's 13F filing for Q2 2017, filed 14 Aug 2017.